Ajanta Pharma - Quaterly Results

01 Feb 2023 Evaluate
The company witnessed a 8.20% growth in the revenue at Rs. 8748.90 millions for the quarter ended December 2022 as compared to Rs. 8085.80 millions during the year-ago period.Profit after Tax for the quarter ended December 2022 saw a decline of -36.34% from Rs. 1947.10 millions to Rs. 1239.60  millions.Operating profit for the quarter ended December 2022 decreased to 1899.20 millions as compared to 2657.70 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 8748.90 8085.80 8.20 25624.10 23750.10 7.89 31406.40 27185.90 15.52
Other Income 305.10 279.00 9.35 1443.00 1113.10 29.64 1397.30 1035.70 34.91
PBIDT 1899.20 2657.70 -28.54 6507.50 8150.50 -20.16 10306.20 10204.80 0.99
Interest 26.80 7.00 282.86 40.20 19.40 107.22 91.20 69.00 32.17
PBDT 1872.40 2650.70 -29.36 6467.30 8131.10 -20.46 10215.00 10135.80 0.78
Depreciation 322.90 307.10 5.14 948.40 908.70 4.37 1209.60 1114.90 8.49
PBT 1549.50 2343.60 -33.88 5518.90 7222.40 -23.59 9005.40 9020.90 -0.17
TAX 309.90 396.50 -21.84 1103.80 1372.20 -19.56 1806.80 2264.50 -20.21
Deferred Tax 134.60 66.60 102.10 55.20 130.00 -57.54 95.10 97.70 -2.66
PAT 1239.60 1947.10 -36.34 4415.10 5850.20 -24.53 7198.60 6756.40 6.54
Equity 257.10 173.90 47.84 257.10 173.90 47.84 171.70 173.90 -1.27
PBIDTM(%) 21.71 32.87 -33.96 25.40 34.32 -26.00 32.82 37.54 -12.58

Ajanta Pharma Share Price

2696.40 -3.30 (-0.12%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×